Published in AIDS on June 01, 1990
Applications of flow cytometry to clinical microbiology. Clin Microbiol Rev (2000) 1.69
Leishmania-reactive CD4+ and CD8+ T cells associated with cure of human cutaneous leishmaniasis. Infect Immun (1994) 1.33
Oral manifestations of HIV infection in children and adults receiving highly active anti-retroviral therapy [HAART] in Dar es Salaam, Tanzania. BMC Oral Health (2006) 1.22
Markers predicting progression of human immunodeficiency virus-related disease. Clin Microbiol Rev (1994) 1.19
Species distribution and in vitro antifungal susceptibility of oral yeast isolates from Tanzanian HIV-infected patients with primary and recurrent oropharyngeal candidiasis. BMC Microbiol (2008) 1.17
Basis for treatment of tuberculosis among HIV-infected patients in Tanzania: the role of chest x-ray and sputum culture. BMC Infect Dis (2008) 1.14
Determination of CD4 and CD8 lymphocyte subsets by a new alternative fluorescence immunoassay. Clin Diagn Lab Immunol (1995) 1.09
Uses of flow cytometry in virology. Clin Microbiol Rev (1994) 1.09
Prevalence of hepatitis B and C viral co-infections among HIV-1 infected individuals in Nairobi, Kenya. BMC Res Notes (2013) 1.08
Do beta-chemokines have clinical relevance in HIV infection? J Clin Invest (1997) 1.07
Changes in natural immunity during the course of HIV-1 infection. Clin Exp Immunol (1993) 1.02
Vertical Transmission of HIV-1. Correlation with maternal viral load and plasma levels of CD4 binding site anti-gp120 antibodies. J Clin Invest (1995) 0.96
Universally applicable three-dimensional hydrodynamic microfluidic flow focusing. Lab Chip (2013) 0.94
Phenotypic and functional characterization of lymphocytes derived from normal and HIV-1-infected human lymph nodes. Clin Exp Immunol (1999) 0.91
Genetic variation of innate immune genes in HIV-infected african patients with or without oropharyngeal candidiasis. J Acquir Immune Defic Syndr (2010) 0.90
Interleukin-2-inducible natural immune (lymphokine-activated killer cell) responses as a functional correlate of progression to AIDS. Clin Diagn Lab Immunol (1994) 0.88
Heterogeneous effects of exogenous IL-2 on HIV-specific cell-mediated immunity (CMI). Clin Exp Immunol (1992) 0.86
Culture and characterisation of epithelial cells from human pterygia. Br J Ophthalmol (1999) 0.85
Increased LAK activity against HIV-infected cell lines in HIV-1+ individuals. Clin Exp Immunol (1992) 0.83
Baseline mycobacterial immune responses in HIV-infected adults primed with bacille Calmette-Guérin during childhood and entering a tuberculosis booster vaccine trial. J Infect Dis (2006) 0.81
Three dimensional microfluidics with embedded microball lenses for parallel and high throughput multicolor fluorescence detection. Biomicrofluidics (2013) 0.78
Clinical field site evaluation of the FACSCount for absolute CD3+, CD3+ CD4+, and CD3+ CD8+ cell count determinations in Thailand. Clin Diagn Lab Immunol (1997) 0.77
Fast sorting of CD4+ T cells from whole blood using glass microbubbles. Technology (Singap World Sci) (2015) 0.77
Improvements in Immune Function and Activation with 48-Week Darunavir/Ritonavir-Based Therapy: GRACE Substudy. ISRN AIDS (2013) 0.75
Plasma viral load and CD4+ lymphocytes as prognostic markers of HIV-1 infection. Ann Intern Med (1997) 16.44
The prognostic value of cellular and serologic markers in infection with human immunodeficiency virus type 1. N Engl J Med (1990) 6.94
Elevated CD38 antigen expression on CD8+ T cells is a stronger marker for the risk of chronic HIV disease progression to AIDS and death in the Multicenter AIDS Cohort Study than CD4+ cell count, soluble immune activation markers, or combinations of HLA-DR and CD38 expression. J Acquir Immune Defic Syndr Hum Retrovirol (1997) 5.30
Changes in T and non-T lymphocyte subsets following seroconversion to HIV-1: stable CD3+ and declining CD3- populations suggest regulatory responses linked to loss of CD4 lymphocytes. The Multicenter AIDS Cohort Study. J Acquir Immune Defic Syndr (1993) 4.92
Failure of T-cell homeostasis preceding AIDS in HIV-1 infection. The Multicenter AIDS Cohort Study. Nat Med (1995) 3.46
Cell-mediated immune response to human immunodeficiency virus (HIV) type 1 in seronegative homosexual men with recent sexual exposure to HIV-1. J Infect Dis (1992) 3.27
Enhanced levels of functional HIV-1 co-receptors on human mucosal T cells demonstrated using intestinal biopsy tissue. AIDS (2000) 2.99
Conversion of logarithmic channel numbers into relative linear fluorescence intensity. Cytometry (1988) 2.96
Shortened telomeres in the expanded CD28-CD8+ cell subset in HIV disease implicate replicative senescence in HIV pathogenesis. AIDS (1996) 2.95
A gentle fixation and permeabilization method for combined cell surface and intracellular staining with improved precision in DNA quantification. Cytometry (1991) 2.60
CD8+ T-lymphocyte activation in HIV-1 disease reflects an aspect of pathogenesis distinct from viral burden and immunodeficiency. J Acquir Immune Defic Syndr Hum Retrovirol (1998) 2.45
Prognostic significance of plasma markers of immune activation, HIV viral load and CD4 T-cell measurements. AIDS (1998) 2.33
Dead cell discrimination with 7-amino-actinomycin D in combination with dual color immunofluorescence in single laser flow cytometry. Cytometry (1992) 2.19
Association of race and gender with HIV-1 RNA levels and immunologic progression. J Acquir Immune Defic Syndr (2000) 2.13
Infection with the human immunodeficiency virus (HIV) is associated with an in vivo increase in B lymphocyte activation and immaturity. J Immunol (1987) 2.11
Viability and recovery of peripheral blood mononuclear cells cryopreserved for up to 12 years in a multicenter study. Clin Diagn Lab Immunol (1999) 2.11
Generation of functional thymocytes in the human adult. Immunity (1999) 2.10
CD4 percentage, CD4 number, and CD4:CD8 ratio in HIV infection: which to choose and how to use. J Acquir Immune Defic Syndr (1989) 2.10
Evaluation of a dual-color flow cytometry immunophenotyping panel in a multicenter quality assurance program. Cytometry (1993) 2.07
A rapid method for measuring apoptosis and dual-color immunofluorescence by single laser flow cytometry. J Immunol Methods (1994) 1.98
Circulating HIV-specific CD8+ cytotoxic T cells express CD38 and HLA-DR antigens. J Immunol (1993) 1.98
Early effects of HIV on CD4 lymphocytes in vivo. J Immunol (1987) 1.87
Influence of HIV-1 infection and cigarette smoking on leukocyte profiles in homosexual men. The Multicenter AIDS Cohort Study. J Acquir Immune Defic Syndr (1992) 1.66
Sensitive method for measuring apoptosis and cell surface phenotype in human thymocytes by flow cytometry. Cytometry (1994) 1.60
Flow cytometry analysis of T cells and continuous T-cell lines from autoimmune MRL/l mice. Nature (1981) 1.56
Virus burden in long-term survivors of human immunodeficiency virus (HIV) infection is a determinant of anti-HIV CD8+ lymphocyte activity. J Infect Dis (1995) 1.53
Natural killer cell immunodeficiency in HIV disease is manifest by profoundly decreased numbers of CD16+CD56+ cells and expansion of a population of CD16dimCD56- cells with low lytic activity. J Acquir Immune Defic Syndr Hum Retrovirol (1995) 1.53
CD20 (pan-B cell) antigen is expressed at a low level on a subpopulation of human T lymphocytes. Cytometry (1993) 1.46
A second isolate of HTLV-II associated with atypical hairy-cell leukemia. N Engl J Med (1986) 1.44
Elevated relative fluorescence intensity of CD38 antigen expression on CD8+ T cells is a marker of poor prognosis in HIV infection: results of 6 years of follow-up. Cytometry (1996) 1.41
Antibodies to human immunodeficiency virus in human sera induce cell-mediated lysis of human immunodeficiency virus-infected cells. J Immunol (1987) 1.34
Quantitation of CD38 expression using QuantiBRITE beads. Cytometry (1998) 1.31
A longitudinal study of neutralizing antibodies and disease progression in HIV-1-infected subjects. J Infect Dis (1999) 1.27
Association of herpesvirus infections with T-lymphocyte-subset alterations, glomerulopathy, and opportunistic infections after renal transplantation. N Engl J Med (1983) 1.23
Detection of cell cycle subcompartments by flow cytometric estimation of DNA-RNA content in combination with dual-color immunofluorescence. Cytometry (2000) 1.22
Standardization of absolute CD4+ lymphocyte counts across laboratories: an evaluation of the Ortho CytoronAbsolute flow cytometry system on normal donors. Cytometry (1995) 1.18
Biosafety guidelines for sorting of unfixed cells. Cytometry (1997) 1.16
Quantitation of CD38 activation antigen expression on CD8+ T cells in HIV-1 infection using CD4 expression on CD4+ T lymphocytes as a biological calibrator. Cytometry (1998) 1.14
Antibody-dependent cellular cytotoxicity against HIV-coated target cells by peripheral blood monocytes from HIV seropositive asymptomatic patients. J Immunol (1990) 1.13
Selective alterations in immunoregulatory lymphocyte subsets in early HIV (human T-lymphotropic virus type III/lymphadenopathy-associated virus) infection. J Clin Immunol (1987) 1.12
B cell reconstitution after human bone marrow transplantation: recapitulation of ontogeny? Bone Marrow Transplant (1993) 1.12
Persistent cytomegalovirus infection of semen increases risk of AIDS. J Infect Dis (1994) 1.11
Decline in total T cell count is associated with onset of AIDS, independent of CD4(+) lymphocyte count: implications for AIDS pathogenesis. Clin Immunol Immunopathol (1998) 1.09
Alterations in cytotoxic and phenotypic subsets of natural killer cells in acquired immune deficiency syndrome (AIDS). J Clin Immunol (1987) 1.08
Phenotypically defined memory CD4+ cells are not selectively decreased in chronic HIV disease. J Acquir Immune Defic Syndr (1994) 1.07
Causal pathways for CCR5 genotype and HIV progression. J Acquir Immune Defic Syndr (2000) 1.07
Effects of anticoagulant, processing delay, and assay method (branched DNA versus reverse transcriptase PCR) on measurement of human immunodeficiency virus type 1 RNA levels in plasma. J Clin Microbiol (1999) 1.07
A clinical, hematologic, and immunologic analysis of 21 HTLV-II-infected intravenous drug users. Blood (1990) 1.05
Treatment of donor bone marrow with monoclonal anti-T-cell antibody and complement for the prevention of graft-versus-host disease. A prospective, randomized, double-blind trial. Ann Intern Med (1986) 1.03
Failure of B cells in common variable immunodeficiency to transit from proliferation to differentiation is associated with altered B cell surface-molecule display. J Allergy Clin Immunol (1989) 1.01
Acute HIV syndrome after discontinuation of antiretroviral therapy in a patient treated before seroconversion. Ann Intern Med (1998) 1.00
Preparation of cells and reagents for flow cytometry. Curr Protoc Immunol (2001) 0.95
Alterations in phenotype and cell-surface antigen expression levels of human monocytes: differential response to in vivo administration of rhM-CSF or rhGM-CSF. Cytometry (1995) 0.95
Activation and differentiation antigens on T cells of healthy, at-risk, and HIV-infected children. J Acquir Immune Defic Syndr (1993) 0.95
Hemoglobin synthesis in cultures of hepatic erythroid cells from the human fetus. Proc Natl Acad Sci U S A (1979) 0.94
Human immunodeficiency virus-1 (HIV-1) gp120 superantigen-binding serum antibodies. A host factor in homosexual HIV-1 transmission. J Clin Invest (1996) 0.93
Applications of a computer simulation model of the natural history of CD4 T-cell number in HIV-infected individuals. AIDS (1991) 0.91
Flow cytometric analysis of live cell proliferation and phenotype in populations with low viability. Cytometry (1999) 0.90
Estrone sulfate promotes human breast cancer cell replication and nuclear uptake of estradiol in MCF-7 cell cultures. Int J Cancer (1993) 0.90
Major expansions of select CD8+ subsets in acute Epstein-Barr virus infection: comparison with chronic human immunodeficiency virus disease. J Infect Dis (1998) 0.90
Potential contributions of viral envelope and host genetic factors in a human immunodeficiency virus type 1-infected long-term survivor. J Virol (1998) 0.88
Rapid evolution of human immunodeficiency virus strains with increased replicative capacity during the seronegative window of primary infection. J Virol (1996) 0.87
Antigen-specific production of RANTES, macrophage inflammatory protein (MIP)-1alpha, and MIP-1beta in vitro is a correlate of reduced human immunodeficiency virus burden in vivo. J Infect Dis (2000) 0.87
A reproducible method to detect CD8 T cell mediated inhibition of HIV production from naturally infected CD4 cells. J Immunol Methods (1993) 0.86
Increased depth of cellular imaging in the intact lung using far-red and near-infrared fluorescent probes. Int J Biomed Imaging (2006) 0.86
Development of antibodies to HIV-1 is associated with an increase in circulating CD3+CD4-CD8- lymphocytes. Clin Immunol Immunopathol (1989) 0.85
Continuous cytotoxic T cell lines reactive against murine plasmacytoma tumor-associated antigens. J Immunol (1981) 0.85
Cytotoxic T lymphocyte lines reactive against murine plasmacytoma antigens: dissociation of cytotoxicity and Lyt-2 expression. Eur J Immunol (1982) 0.84
Accelerated changes (inflection points) in levels of serum immune activation markers and CD4+ and CD8+ T cells prior to AIDS onset. J Acquir Immune Defic Syndr Hum Retrovirol (1998) 0.83
Calculation and use of an HIV-1 disease progression score. AIDS (2000) 0.83
The relationship between T-cell levels and CMV infection in asymptomatic HIV-1 antibody-positive homosexual men. J Acquir Immune Defic Syndr (1993) 0.83
Normal range estimation for repeated immunologic measures. Clin Diagn Lab Immunol (1996) 0.83
Simultaneous flow cytometric measurement of viability and lymphocyte subset proliferation. J Immunol Methods (2001) 0.83
Immunomodulating effects in vitro of interleukin-2 and interferon-gamma on human blood and bone marrow mononuclear cells. Nat Immun Cell Growth Regul (1988) 0.82
Serum and effector-cell antibody-dependent cellular cytotoxicity (ADCC) activity remains high during human immunodeficiency virus (HIV) disease progression. J Clin Immunol (1989) 0.81
Detection of infection with human immunodeficiency virus type 1 before seroconversion: correlation with clinical symptoms and outcome. J Infect Dis (1997) 0.80
Functional reconstitution of thymopoiesis after human immunodeficiency virus infection. J Virol (2000) 0.79
Patterns of CD4+ cell changes after HIV-1 infection indicate the existence of a codeterminant of AIDS. J Acquir Immune Defic Syndr (1988) 0.79
Interferon-induced expression of class II major histocompatibility antigens in the major histocompatibility complex (MHC) class II deficiency syndrome. J Clin Immunol (1988) 0.79
A simple and rapid method for preparation of HIV-expressing targets for functional assays. J Immunol Methods (1988) 0.78
Resistance to HIV infection may be genetically mediated. AIDS (1996) 0.78
HIV-1 from a seronegative transplant donor. N Engl J Med (1992) 0.77
Gamma-interferon-induced monocyte major histocompatibility complex class II antigen expression individuals with acquired immune deficiency syndrome. Cell Immunol (1989) 0.77
Influence of HIV-1 infection and cigarette smoking on leukocyte profile in homosexual men. Ann N Y Acad Sci (1993) 0.77
Tumor immunity to murine plasma cell tumors. VII. Expression of H-2 and tumor antigens on Ig synthesis variants of MPC-11. Int J Cancer (1982) 0.77
Measurement of lymphocyte subset proliferation by three-color immunofluorescence and DNA flow cytometry. J Immunol Methods (2000) 0.77
Persistently seronegative men from whom HIV-1 has been isolated are genetically and immunologically distinct. Immunol Lett (1996) 0.77
Increased levels of anti-CCR5 antibodies in sera from individuals immunized with allogeneic lymphocytes. AIDS (2000) 0.76
Immunology of HIV infection. Int Rev Immunol (1990) 0.76
AIDS onset at high CD4+ cell levels is associated with high HIV load. AIDS Res Hum Retroviruses (2000) 0.76
Selective decrease in Leu8-negative T cell subpopulations following treatment with recombinant interferon-alpha 2a (rIFN-alpha 2a). Cell Immunol (1988) 0.75
The response of various hematologic parameters in the young bovine subjected to multiple phlebotomies. ASAIO J (1996) 0.75
Monitoring immunosuppression following renal transplantation. Diagn Immunol (1983) 0.75
B cell dysfunction after bone marrow transplantation is associated with decreased Ca2+ flux upon membrane Ig crosslinking. Clin Immunol Immunopathol (1994) 0.75
Tumor immunity to murine plasma-cell tumors. VIII. Immunosuppression of the generation of cytotoxic T cells by murine plasma-cell tumor lines. Int J Cancer (1983) 0.75
Cellular and humoral immune responses of mice during immunological enhancement of an allogeneic tumor. Transplantation (1978) 0.75